Move for MDS Walk October 20, 2024 Boston, MA Register for your local Move for MDS community walk, fundraise and show support to those effected by MDS by joining the…
Move for MDS Walk September 22, 2024 New York, NY Register for your local Move for MDS community walk, fundraise and show support to those effected by MDS by joining…
Move for MDS Walk August 25, 2024 Chicago, IL Register for your local Move for MDS community walk, fundraise and show support to those effected by MDS by joining the…
MDS Patient & Family Forum May 11, 2024 St. Louis, MO Many patients and caregivers have never met another person diagnosed with MDS until they connected with them at one…
Move for MDS Walk May 5, 2024 Nashville, TN Register for your local Move for MDS community walk, fundraise and show support to those effected by MDS by joining the…
Move for MDS Walk April 7, 2024 Tampa, FL Register for your local Move for MDS community walk, fundraise and show support to those effected by MDS by joining the…
MDS Patient & Family Forum April 6, 2024 Baltimore, MD Many patients and caregivers have never met another person diagnosed with MDS until they connected with them at one of…
3rd Regional Symposium on Myelodysplastic Syndromes March 15-16, 2024 Kyoto, Japan The 3rd Regional Symposium on Myelodysplastic Syndromes will take place from 15-16 March 2024, in Kyoto, Japan. MDS is…
MDS Foundation Breakfast Symposium December 8, 2023 In conjunction with the 65th American Society of Hematology Annual Meeting and Exposition The 2023 Symposium will focus on recent advances in the…
MDS/MPN Overlap Syndrome Webinar November 4, 2023 In this webinar, Dr. Angela Fleischman will explain myelodysplastic syndromes/myeloproliferative neoplasms overlap syndrome with an overview of the different features between MDS and…
MDS Patient & Family/Caregiver Forum October 14, 2023 Nashville, TN Many patients and caregivers have never met another person diagnosed with MDS until they connected with them at one of…
MDS Patient & Family/Caregiver Forum October 7, 2023 Philadelphia, PA Many patients and caregivers have never met another person diagnosed with MDS until they connected with them at one of…
MDS Patient & Family/Caregiver Forum September 9, 2023 Los Angeles, CA Many patients and caregivers have never met another person diagnosed with MDS until they connected with them at one…
CHIP and CCUS, Precursors to MDS August 19, 2023 There have been marked developments in the understanding of clonal hematopoiesis based on findings of somatic mutations in genes known to…
In 2020, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to magrolimab for the treatment of newly diagnosed myelodysplastic syndromes (MDS). This designation is designed to expedite…
Updates from the 17th International Congress on MDS: Promising Treatment Advances July 29, 2023 In this webinar, Dr. Moshe Mittelman will provide an overview of the most promising research presented…
Effective June 1, 2023, the FDA lifted its clinical hold on Foghorn Therapeutics’ Phase 1 study of FHD-286 dose escalation in patients with acute myeloid leukemia and myelodysplastic syndromes. The…
Omisirge (omidubicel) is the first allogeneic (from a donor) product for SCT that has been the recipient of FDA approval. The FDA's nod moves Omisirge into the realm of…
Psychological Well-Being and MDS April 22, 2023 In this webinar, Dr. Hermioni Amonoo will share her tools for taking care of your mental health and emotional well-being following a cancer…
MDS Patient & Family/Caregiver Forum November 19, 2022 Presenters: Jeffrey J. Pu, MD, PhD, The University of Arizona Cancer Center Laura M. F. McPheeters, FNP-C, The University of Arizona Cancer…
MDS Patient & Family/Caregiver Forum November 5, 2022 Presenters: Stephen Chung, MD Yazan Madanat, MD Madhuri Vusirikala, MD Amber Thomassen, AGPCNP-BC, AOCNP Whether you are a newly diagnosed patient, a…
The 1st International Workshop on Myelodysplastic Syndromes was held this year in Miami, FL from June 24-26. This in-person event was a convergence of researchers and clinicians to discuss advances…
MDS Patient & Family/Caregiver Forum September 10, 2022 Presenters: Paul J. Shami, MD and Afaf Osman, MD, Huntsman Cancer Center Ashley Moncrief, RN, BSN, Vanderbilt University Medical Center Whether you…
Karyopharm Therapeutics, a pharmaceutical company focusing on novel cancer therapies, has issued a statement via PR Newswire that the FDA has granted regulatory designations to eltanexor, Karyopharm’s Selective Inhibitor…
In an August 3rd, 2022 news release from Syros Pharmaceuticals (“Syros”), the company shared that its product tamibarotene had received a positive opinion for its Orphan Drug designation application.…
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
